Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pomalidomide, Cyclophosphamide, and Dexamethasone in Relapsed Refractory Myeloma
NCT03601624Phase 2Unknown
- Sponsor
- ISSSTE
- Start
- Sep 2018
- Primary completion
- Dec 2018
- Modality
- Molecular Glues
- Countries
- 1
01
Overview
A Phase 2 trial of pomalidomide in multiple myeloma (MM), sponsored by ISSSTE. Status: unknown.
02
Drugs
pomalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT03601624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03601624.